Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study

BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease globally. Direct acting antivirals (DAAs) have proven effective in curing HCV. However, the current standard of care (SOC) in Botswana remains PEGylated interferon-α (IFN-α) with ribavirin. Several mutations have...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhebhe, Lynnette, Anderson, Motswedi, Souda, Sajini, Choga, Wonderful T., Zumbika, Edward, Shaver, Zachary M., Mbangiwa, Tshepiso, Phinius, Bonolo B., Banda, Chabeni C., Melamu, Pinkie, Musonda, Rosemary M., Essex, Max, Blackard, Jason T., Moyo, Sikhulile, Gaseitsiwe, Simani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805647/
https://www.ncbi.nlm.nih.gov/pubmed/31640596
http://dx.doi.org/10.1186/s12879-019-4514-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805647/
https://www.ncbi.nlm.nih.gov/pubmed/31640596
http://dx.doi.org/10.1186/s12879-019-4514-1

Ejemplares similares